J.M. Kern, V. Maass, M. Maass  Clinical Microbiology and Infection 

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
P.-Y. Lévy  Clinical Microbiology and Infection 
R. Dumke, H. von Baum, P.C. Lück, E. Jacobs 
L. Boyanova  Clinical Microbiology and Infection 
H. Lepidi, F. Gouriet, D. Raoult  Clinical Microbiology and Infection 
P. Melin  Clinical Microbiology and Infection 
Gut bacterial microbiota and obesity
Human papilloma viruses and cancer in the post-vaccine era
The persistence of humoral and cellular immunities more than three decades after smallpox vaccination  S.-H. Kim, S.-G. Yeo, K.-H. Park, J.-W. Bang, H.-B.
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
Recruitment of myeloid and plasmacytoid dendritic cells in cervical mucosa during Chlamydia trachomatis infection  T. Agrawal, V. Vats, P.K. Wallace,
In vitro effects of cefotaxime and ceftriaxone on Salmonella typhi within human monocyte-derived macrophages  B. Ekinci, A.Y. Coban, A. Birinci, B. Durupinar,
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Virological tools to diagnose and monitor hepatitis C virus infection
R. Cantón  Clinical Microbiology and Infection 
Genital Chlamydia trachomatis infections
Link between intracellular pathogens and cardiovascular diseases
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Non-antibiotic strategies for sepsis
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Trends in antibiotic prescribing in general internal medicine wards: antibiotic use and indication for prescription  B. Maraha, M. Bonten, H. Fiolet,
Effect of moxifloxacin on secretion of cytokines by human monocytes stimulated with lipopolysaccharide  F.G. Araujo, T.L. Slifer, J.S. Remington  Clinical.
Vector control: a cornerstone in the malaria elimination campaign
L. Y. A. Chai, R. Naesens, A. L. Khoo, M. V. Abeele, K
Training for the infectious diseases speciality in Norway
Isospora belli Clinical Microbiology and Infection
Estimation of delay in detecting hepatitis C virus antibodies in pools compared to individual testing on seroconversion panels  B. Sarov, L. Novack, N.
B. Gordts  Clinical Microbiology and Infection 
CMI editorial report 2011 Clinical Microbiology and Infection
P.M. Keig, E. Ingham, P.A.R. Vandamme, K.G. Kerr 
Elements of design: the knowledge on which we build
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Levofloxacin in the treatment of ventilator-associated pneumonia
R. Bitterman, M. Paul, D. Polak, Y. Geffen 
Metagenomics and probiotics
Laboratory diagnosis of Clostridium difficile disease
A case of pleurisy associated with antibodies to Rickettsia conorii
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
Pathogenesis of catheter-related infections: lessons for new designs
J. Garau  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Systematic review of antibiotic consumption in acute care hospitals
Antibacterial drug discovery in the 21st century
Abstracts cont. Clinical Microbiology and Infection
Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection  R. Nir-Paz, A. Michael-Gayego, M. Ron, C.
Antimicrobial drug development – the past, the present, and the future
Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia  M.-S. Hsu,
An after-hours clinical liaison blood culture service—is it worth it?
Statin use and clinical outcomes among pneumonia patients
Isolation of Coxiella burnetii from the blood of a patient with positive Anaplasma phagocytophilum serological results  A.S. Santos, R. de Sousa, F. Alves,
Clinical Microbiology and Infection
The medical importance of Chlamydiae
Overview of cefixime use in community-acquired infections
The atypical pneumonias: clinical diagnosis and importance
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
A. Ramette, J.M. Tiedje, A. Boetius 
Modelling during an emergency: the 2009 H1N1 influenza pandemic
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
Rajko Saletinger, Mario Poljak, Franc Strle 
The future of diagnostic bacteriology
Presentation transcript:

Molecular pathogenesis of chronic Chlamydia pneumoniae infection: a brief overview  J.M. Kern, V. Maass, M. Maass  Clinical Microbiology and Infection  Volume 15, Issue 1, Pages 36-41 (January 2009) DOI: 10.1111/j.1469-0691.2008.02631.x Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Immunofluorescence microscopy of a chronically Chlamydia pneumoniae-infected peripheral human blood monocyte (a) and an acutely infected respiratory epithelial HEp2 cell (b) 72 h post-infection (fluorescein isothiocyanate-labeled anti-Chlamydia lipopolysaccharide antibody; Dako, Hamburg, Germany). (a) Persistent chlamydial infection can be detected over prolonged periods in mononuclear cells ex vivo. Peripheral blood mononuclear cells can differentiate into monocyte-derived macrophages or into dendritic cells. The numerous small and morphologically aberrant inclusions seen here are indicative of persistent infection (arrow). Their appearance does not alter substantially over the lifetime of the cell, and they do not release new infective elementary bodies. (b) Typical productive infection in epithelial cells (HEp-2 cells) characterized by large inclusions filled with abundant elementary bodies ready for release by host cell lysis. This is the in vitro equivalent of acute infection leading to cell death. Clinical Microbiology and Infection 2009 15, 36-41DOI: (10.1111/j.1469-0691.2008.02631.x) Copyright © 2009 European Society of Clinical Infectious Diseases Terms and Conditions